Bacteremia
Information
- Disease name
- Bacteremia
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05296590 | Active, not recruiting | Monocyte Distribution Width (MDW) in the General Population of Emergency Department Patients With and Without Bacteremia | July 1, 2021 | June 2026 | |
| NCT06300736 | Active, not recruiting | Design of a Predictive Score for Contamination of Pediatric Blood Cultures | January 1, 2022 | October 1, 2024 | |
| NCT05522764 | Active, not recruiting | Predictors of Infective Endocarditis Among Patients Managed for Staphylococcus Aureus Bacteremia, Particularly Staphylococcus Aureus Bacteriuria, and Time to Blood Culture Positivity | July 18, 2022 | December 31, 2023 | |
| NCT00122642 | Completed | Phase 2/Phase 3 | Alcohol Locks for the Prevention of Tunneled Catheter-related Infections | August 2005 | September 2009 |
| NCT00130221 | Completed | Phase 1 | Skin Cleansing With Chlorhexidine to Decrease Hospital Acquired Infections | June 2005 | July 26, 2006 |
| NCT00177736 | Completed | Pharmacodynamic Parameters of Two Different Doses of Cefepime | September 2005 | December 2007 | |
| NCT00235690 | Completed | N/A | Optimizing Dosing of Colistin for Infections Resistant to All Other Antibiotics, Approved NIH Protocol Dated 12.06.07(DMID Protocol #07-0036) | June 2008 | August 2015 |
| NCT00027248 | Completed | Phase 3 | Safety and Efficacy of MBI 226 for the Prevention of Central Venous Catheter-Related Bloodstream Infections | September 2000 | July 2003 |
| NCT00037050 | Completed | Phase 3 | Antibiotic Treatment for Infections of Short Term In-dwelling Vascular Catheters Due to Gram Positive Bacteria | April 2002 | July 2005 |
| NCT00093067 | Completed | Phase 3 | Daptomycin in the Treatment of Subjects With Infective Endocarditis or Bacteremia Due to S. Aureus | March 2002 | February 2005 |
| NCT01394458 | Completed | N/A | Efficacy and Safety of an Ethanol/Sodium Citrate Locking Solution: A Pilot Study | August 2011 | November 2013 |
| NCT01410578 | Completed | The Value of sTREM-1, PCT, and CRP as Markers for the Detection of Sepsis and Bacteremia Among Patients With a FUO | September 2009 | March 2011 | |
| NCT01413555 | Completed | N/A | Multicenter Blood Culture Quality Improvement | August 2011 | March 2013 |
| NCT01450358 | Completed | Phase 4 | Evaluation in the Treatment of Nosocomial Sepsis Comparing Polymerase Chain Reaction With Conventional Blood Culture. | January 2012 | May 2016 |
| NCT01551667 | Completed | Immune Response of Patients With Chronic, Staphylococcus Aureus-infected Wounds | November 2012 | March 2016 | |
| NCT01563406 | Completed | N/A | Hub Cleansing to Prevent Hub Infection | March 2012 | June 2013 |
| NCT01728376 | Completed | Phase 4 | Safety & Efficacy of Daptomycin Versus Standard of Care (SOC) in 1 - 17 Year Olds With Staphylococcus Aureus Bacteremia (MK-3009-005) | November 29, 2012 | January 20, 2016 |
| NCT01867905 | Completed | Antibiotic Administration and Blood Culture Positivity in Severe Sepsis and Septic Shock | March 1, 2014 | April 10, 2019 | |
| NCT01898208 | Completed | N/A | Rapid Identification and Susceptibility Testing of Pathogens From Blood Cultures | August 2013 | August 2014 |
| NCT01919593 | Completed | Phase 4 | Efficacy of 2% Chlorhexidine Gluconate in 70% Alcohol Compare 10% Povidone Iodine in Blood Culture in Children | January 2012 | April 2013 |
| NCT01919762 | Completed | Detecting Infections Rapidly and Easily for Bacteremia Trial (DIREBT) | August 2013 | August 2015 | |
| NCT02025699 | Completed | Prospective Study to Characterize Host-pathogen Related Factors in Hospitalized and ED Patients With LRTI and/or Sepsis | February 2014 | September 2016 | |
| NCT02026895 | Completed | N/A | Virulence of Staphylococcus Lugdunensis in Severe Infections | December 2013 | February 2016 |
| NCT02115776 | Completed | N/A | A New Antibiotic Prophylaxis Regimen to Prevent Bacteremia Following Dental Procedures | January 2014 | May 2015 |
| NCT02150031 | Completed | Phase 4 | Bacteraemia Secondary to Tooth Extraction: Chlorhexidine Prophylaxis Protocols | December 2010 | June 2012 |
| NCT02168946 | Completed | Phase 3 | Efficacy, Safety, Tolerability of Vabomere Compared to Best Available Therapy in Treating Serious Infections in Adults | July 2014 | July 21, 2017 |
| NCT02210169 | Completed | N/A | RCT of Continuous Versus Intermittent Infusion of Vancomycin in Neonates | September 2014 | May 2018 |
| NCT02261506 | Completed | N/A | Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness: A Pilot RCT | October 16, 2014 | October 5, 2017 |
| NCT02420366 | Completed | Study of Cases of Serious Infections Due to Carbapenem-Resistant Enterobacteriaceae | May 2014 | January 2015 | |
| NCT02482051 | Completed | Ultra Rapid Culture Independent Detection of High-Priority Carbapenem Resistant Enterobacteriaceae Directly From Blood | July 2015 | January 31, 2022 | |
| NCT02535468 | Completed | T2Bacteria Panel Pivotal Study | December 2015 | June 2016 | |
| NCT02536352 | Completed | Early Phase 1 | Effect of Supplementation of Fluoride on Maternal Periodontal Health, Preterm Delivery, and Perinatal Well-Being | October 2015 | October 1, 2019 |
| NCT02599220 | Completed | Clinical Outcomes and Cost of Gram Negative Bacteremia | January 2002 | May 2015 | |
| NCT02660346 | Completed | Phase 4 | IL-10 Stratifying Tool for Towards Antibiotic Selection for MRSaB | November 2015 | January 30, 2018 |
| NCT02719769 | Completed | Clinical Performance of the Accelerate ID/AST System for Positive Blood Culture | January 2016 | January 12, 2017 | |
| NCT02774850 | Completed | Home Away From Home - Medical Outcomes | June 2015 | July 26, 2019 | |
| NCT02784821 | Completed | Phase 2 | Antibiotic "Dysbiosis" in Preterm Infants | January 16, 2017 | September 11, 2019 |
| NCT02852902 | Completed | Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to ESBL- or Carbapenemase-producing Enterobacterales in Solid Organ Transplantation: an Observational Multinational Study. | January 1, 2016 | January 1, 2018 | |
| NCT02869191 | Completed | Blood Cultures's Profitability in Intensive Care Unit | October 2012 | July 2018 | |
| NCT02914132 | Completed | N/A | Safety Evaluation of Seraph® 100 to Reduce Bacteremia in Patients on Hemodialysis | February 2016 | June 7, 2018 |
| NCT02917551 | Completed | N/A | BALANCE on the Wards: A Pilot RCT | October 10, 2016 | January 30, 2020 |
| NCT02972983 | Completed | Phase 4 | Daptomycin as Adjunctive Therapy for Staphylococcus Aureus Bacteremia | December 1, 2016 | September 2019 |
| NCT02988414 | Completed | Diagnosis of Bacteremia/Septicemia and Culture Negative Endocarditis by the Karius Sequencing-Based Infectious Disease Diagnostic Assay | July 2016 | April 2017 | |
| NCT03005145 | Completed | N/A | Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness | February 24, 2017 | August 3, 2023 |
| NCT03148769 | Completed | Spanish Bacteriemia Cohort 2016: Epidemiology, Clinical Management and Prognosis Factors | October 2016 | May 2019 | |
| NCT03153384 | Completed | Impact of the Blood Culture Technique on the Diagnosis of Infective Endocarditis | November 11, 2017 | July 8, 2022 | |
| NCT03162250 | Completed | Phase 1 | Study to Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S in Participants With Staphylococcus Aureus Bacteremia Receiving Standard-of-Care (SOC) Antibiotics | July 13, 2017 | January 15, 2020 |
| NCT03224052 | Completed | Empirical ANtibiotic THErapy in Adults Hospitalised With Malaria | May 1, 2016 | January 1, 2018 | |
| NCT03309137 | Completed | N/A | Device for Bacteremia Prevention in Post Cardiac Surgical Intensive Care Unit Patients | November 19, 2017 | November 30, 2020 |
| NCT03441126 | Completed | Blood Culture Improvement Guidelines and Diagnostic Stewardship for Antibiotic Reduction in Critically Ill Children | April 1, 2018 | December 28, 2021 | |
| NCT03597841 | Completed | Turkish Prospective Cohort Study on Carbapenem Resistant Klebsiella Pneumonia Bacteremia | June 25, 2018 | July 22, 2019 | |
| NCT03643952 | Completed | Phase 2 | Safety, Efficacy, and Pharmacokinetics (PK) of Daptomycin (MK-3009) in Japanese Pediatric Subjects With Complicated Skin and Soft Tissue Infections (cSSTI) and Bacteremia (MK-3009-029) | December 6, 2018 | April 7, 2020 |
| NCT03765749 | Completed | Empirical Antibiotic and Outcome in Community-onset Bacteremia | November 22, 2018 | December 31, 2021 | |
| NCT03841162 | Completed | Fast Assay for Pathogen Identification and Characterization | February 12, 2019 | April 17, 2020 | |
| NCT03894046 | Completed | Phase 3 | Study to Evaluate the Efficacy and Safety of Intravenous Sulbactam-ETX2514 in the Treatment of Patients With Infections Caused by Acinetobacter Baumannii-calcoaceticus Complex | September 5, 2019 | July 26, 2021 |
| NCT03925402 | Completed | Ertapenem for Initial Empirical Treatment of Third Generation Cephalosporin Resistant Enterobacteriaceae Bacteremia | May 15, 2019 | October 1, 2022 | |
| NCT03937245 | Completed | Epidemiology and Determinants of Outcomes of Hospital Acquired Blood Stream Infections in the Intensive Care | August 30, 2019 | June 3, 2021 | |
| NCT04008446 | Completed | Effect of Vitamin B12 on the Development of Sepsis, in Culture Positive Patients | June 1, 2019 | December 31, 2022 | |
| NCT04042636 | Completed | Epidemiologic Patterns of Bacteremia After Trauma | January 1, 2011 | December 31, 2018 | |
| NCT04044703 | Completed | Phase 4 | Improving Dosing of Vancomycin in Young Infants With Infections | August 30, 2019 | January 3, 2021 |
| NCT04103203 | Completed | N/A | Fast Assay for Pathogen Identification - Quasi-Experimental Intervention Study | July 1, 2019 | April 30, 2020 |
| NCT04295915 | Completed | Clinical Performance and Reproducibility of the Accelerate PhenoTest™ Blood Culture (BC) Kit With New Antibiotic Wave I Updates | March 11, 2020 | April 19, 2022 | |
| NCT04573894 | Completed | Diagnostic Performance of Plasma Procalcitonin for the Detection of Blood Cultures Contaminations | June 1, 2020 | September 5, 2020 | |
| NCT04823026 | Completed | Host RNA Profiles to Detect Infections in Young Infants | May 15, 2020 | December 31, 2021 | |
| NCT04825132 | Completed | N/A | Infectious Diseases in Aged Population | April 1, 2021 | November 30, 2023 |
| NCT04882085 | Completed | Phase 4 | Efficacy and Safety of CAZ-AVI in the Treatment of Infections Due to Carbapenem-resistant G- Pathogens in Chinese Adults | August 26, 2021 | August 31, 2023 |
| NCT05236283 | Completed | Epidemiology of Bacteremia at Two Tertiary ICUs in Switzerland | February 1, 2022 | March 30, 2022 | |
| NCT05314816 | Completed | N/A | Rapid Blood Culture Identification Panel in Pediatric Patients in Guatemala | April 7, 2022 | November 28, 2022 |
| NCT05535751 | Completed | Cefepime vs. Carbapenems for Treating AmpC β-lactamase-producing Enterobacteriaceae Bloodstream Infections | July 20, 2022 | June 20, 2023 | |
| NCT05585463 | Completed | Safety of Acupuncture and Intracutaneous Needles in Pediatric Cancer Patients: a Retrospective Study (ACUSAFE2021) | September 1, 2019 | October 31, 2021 | |
| NCT05640349 | Completed | Evaluation of Bacteremia Epidemiology During the COVID Period in One French University Hospital | April 15, 2022 | September 30, 2022 | |
| NCT05686577 | Completed | How to Reduce Unnecessary Blood Cultures: Construction and Validation of a Predictive Score for Blood Culture Positivity in Intensive Care | November 22, 2022 | October 25, 2023 | |
| NCT05959928 | Completed | Continuous Temperature Telemonitoring of Patients With COVID-19 and Other Infectious Diseases in Hospital at Home Using Viture | February 9, 2021 | June 2, 2021 | |
| NCT06141395 | Completed | NGS-Based Assay of Blood Samples of Sepsis Patients for Rapid Bacterial Identification | November 16, 2023 | March 14, 2024 | |
| NCT00319826 | Completed | Virulence Determinants in S Aureus Bacteremia | March 2004 | August 2013 | |
| NCT00398411 | Completed | Phase 3 | Moxifloxacin in the Prevention of Bacteremia After High-dose Chemotherapy and Transplantation of Peripheral Stem Cells | October 2006 | December 2008 |
| NCT00406198 | Completed | Phase 4 | Impact of Continuous Venovenous Haemofiltration on Organ Failure During the Early Phase of Severe Sepsis | March 1997 | December 1999 |
| NCT00414193 | Completed | Piperacillin/Tazobactam for Bacteremia With Organisms Producing Chromosomally-Encoded AmpC Beta-Lactamase | February 2007 | December 2017 | |
| NCT00414362 | Completed | Clinical Impact of Fluoroquinolone Resistance in Bacteremia Caused by Gram-Negative Bacilli of Urinary Tract Origin | February 2007 | June 2017 | |
| NCT00417235 | Completed | Phase 4 | Dressing: Frequency of Change and Evaluation of an Antiseptic-Impregnated Catheter Dressing in ICU Patients | January 2007 | June 2008 |
| NCT00454285 | Completed | Phase 2 | Bacteria Entering the Blood Stream From Tooth Extractions and Tooth Brushing | January 2003 | June 2006 |
| NCT00515151 | Completed | Phase 4 | Prevention of Catheter-Associated Infection With the Skin Disinfectant Octenidine Dihydrochloride | May 2002 | April 2005 |
| NCT00548002 | Completed | Combination Therapy With Fluoroquinolone in Staphylococcus Aureus Bacteremia | January 1999 | August 2002 | |
| NCT00571259 | Completed | Phase 4 | Prophylactic Antimicrobial Catheter Lock | September 2003 | January 2010 |
| NCT00609375 | Completed | Phase 4 | Efficacy of Cefepime Continuous Infusion Versus an Intermittent Dosing Regimen | September 2006 | December 2007 |
| NCT00692848 | Completed | N/A | Impact of Procalcitonin on the Management of Children Aged 1 to 36 Month Presenting With a Fever Without a Source | November 2006 | June 2008 |
| NCT00714402 | Completed | Procalcitonin Level and Kinetics in Children With Bacterial Infections | August 2008 | ||
| NCT00735813 | Completed | Phase 3 | Taurolidine Lock Solution in the Prevention of Catheter Related Bacteremia | April 2008 | September 2012 |
| NCT00814151 | Completed | MicroPhage S. Aureus / MSSA / MRSA Blood Culture Beta Trial | July 2008 | December 2008 | |
| NCT00965198 | Completed | Comparison of Infection Rates Among Patients Using Two Catheter Access Devices | November 2009 | July 2011 | |
| NCT00973063 | Completed | N/A | Effectiveness of Routine Sterile Gloving in Blood Culture | March 2009 | December 2009 |
| NCT01023555 | Completed | N/A | Increasing the Yield of Blood Cultures in Neonates | January 2010 | July 2010 |
| NCT01039259 | Completed | The Impact of Material on Microbiota in Association With Tongue and Lip Piercing | August 2008 | February 2009 | |
| NCT01179022 | Completed | Incidence of Bacteremia Following Argon Plasma Coagulation in Patients With Endobronchial Lesions | October 2010 | October 2012 | |
| NCT01184339 | Completed | Prospective Study Into the Performance of the MicroPhage S. Aureus/MSSA/MRSA Test Direct From Blood Culture Positives | August 2009 | August 2010 | |
| NCT01191840 | Completed | Phase 2 | Treatment Algorithm to Reduce the Use of Vancomycin in Adults With Blood Stream Infection | February 2011 | March 4, 2017 |
| NCT01198262 | Completed | Rapid Test to Detect Staphylococcus Aureus in Blood and Wound Infections | April 2008 | August 2010 | |
| NCT01216761 | Completed | N/A | A Cluster-randomized Cross-over Trial Evaluating the Comparative Effectiveness of Three Skin Antiseptic Interventions | May 2008 | November 2009 |
| NCT01321879 | Completed | Phase 2 | Study to Evaluate the Safety and Efficacy of Telavancin in the Treatment of Gram Positive Bloodstream Infections in Cancer Patients | March 2011 | December 2016 |
| NCT01359891 | Completed | Clinical Evaluation of Novel Biomarkers in Patients With Septicemia | November 2010 | August 2021 | |
| NCT04636554 | No longer available | Personalized Phage Treatment in Covid-19 Patients With Bacterial Co-Infections Microbials for Pneumonia or Bacteremia/Septicemia | |||
| NCT06457386 | Not yet recruiting | N/A | Echocardiography Versus no Echocardiography in S. Aureus Bacteraemia and VIRSTA Score < 3 | December 2024 | December 2028 |
| NCT05799716 | Not yet recruiting | Phase 4 | Treating Donors With Intravenous Immunoglobulin to Reduce Donor-Derived Infections | April 1, 2023 | September 1, 2024 |
| NCT05770622 | Not yet recruiting | Phase 4 | Improving Therapeutic Drug Monitoring and Dosing for Vancomycin in Young Infants With Infections (VANCAPP) (Part 2) | April 2024 | March 2025 |
| NCT06425367 | Not yet recruiting | N/A | Impact of Performing a Rapid Antibiotic Susceptibility Test on Antibiotic Therapy Adaptation in Adult Patients With Enterobacterales Bacteremia | June 15, 2024 | June 15, 2025 |
| NCT06422221 | Not yet recruiting | Phase 4 | An Oral Doxycycline Regimen to Prevent Bacteremia Following Dental Procedures | July 15, 2024 | June 30, 2025 |
| NCT04065750 | Not yet recruiting | Exposure to Antibiotics and Incidence of Bacteraemia Caused by Resistant Bacteria | November 13, 2023 | December 2023 | |
| NCT05521880 | Not yet recruiting | Phase 4 | Anchoring Sequential Intermittent Long Acting Antimicrobials With Medication for Opioid Use Disorder (MOUD) for Invasive Infections Related to Opioid Use | May 2024 | May 2025 |
| NCT06419296 | Not yet recruiting | Mortality of MBL-producing Enterobacteriaceae Bacteremias With the Combined Use of Ceftazidime-avibactam and Aztreonam vs. Other Active Antibiotics. A Multicenter Target Trial Emulation. | May 15, 2024 | July 1, 2024 | |
| NCT04821661 | Recruiting | T2 and SeptiCyte RAPID Duration Project | January 11, 2022 | August 31, 2023 | |
| NCT03671967 | Recruiting | Phase 4 | PipEracillin Tazobactam Versus mERoPENem for Treatment of Bloodstream Infections Caused by Cephalosporin-resistant Enterobacteriaceae (PETERPEN) | May 1, 2019 | April 2026 |
| NCT06218277 | Recruiting | N/A | Rapid Antimicrobial Susceptibility Testing With MIC Directly From Positive Blood Cultures With ASTar | January 10, 2024 | December 31, 2024 |
| NCT00901602 | Recruiting | Lebanese Interhospital Pneumococcal Surveillance Program | October 2005 | October 2030 | |
| NCT05721781 | Recruiting | N/A | Reducing Risk for Infective Endocarditis | August 31, 2023 | September 2027 |
| NCT04478721 | Recruiting | Phase 3 | Temocillin vs Meropenem for the Targeted Treatment of Bacteraemia Resistant to Third Gen Cephalosporins | December 15, 2020 | September 2023 |
| NCT04565691 | Recruiting | N/A | Bacteremia From Periodontal Treatment to Elucidate the Underpinnings of Sepsis | February 25, 2019 | December 31, 2027 |
| NCT05741424 | Recruiting | Impact of BacT/Alert® VIRTUO®, BioFire® Blood Culture Identification 2-BCID2 and REVEAL® (bioMérieux) on the Optimization of Antibiotic Therapy for Gram-negative Bacteremia in the ICU | March 8, 2023 | July 2024 | |
| NCT02979951 | Recruiting | Fosfomycin i.v. for Treatment of Severely Infected Patients | December 2016 | December 2030 | |
| NCT05950984 | Recruiting | Medical Device (MD) Derived Pharmacokinetic (PK) Parameters for Vancomycin (MD-PK) | October 30, 2023 | August 2024 | |
| NCT05184764 | Recruiting | Phase 1/Phase 2 | Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia | April 26, 2022 | March 2025 |
| NCT05224401 | Recruiting | Phase 3 | Pivmecillinam With Amoxicillin/Clavulanic Acid for Step Down Oral Therapy in ESBL UTIs | May 29, 2023 | September 1, 2027 |
| NCT05355350 | Suspended | Phase 4 | PipEracillin/Tazobactam Versus mERoPENem for Treatment of AmpC Producing Blood Stream Infections | July 1, 2022 | April 15, 2028 |
| NCT00164099 | Terminated | Phase 4 | The Role of Synbiotics in Reducing Post-Operative Infections in Patients Undergoing Cardiac Surgery: A Pilot Study | November 2005 | June 2007 |
| NCT05210387 | Terminated | N/A | Seven Versus 14 Days of Antibiotic Therapy for Multidrug-resistant Gram-negative Bacilli Infections | January 27, 2022 | December 31, 2023 |
| NCT01365312 | Terminated | N/A | Safety and Efficacy Study of Ethanol Locking to Prevent Central Line Infection in Premature Neonates | February 2010 | |
| NCT01388686 | Terminated | Prevalence of CVC-associated Sepsis and Use of Blood Cultures in Berlin - Brandenburg | August 2009 | November 2015 | |
| NCT00835783 | Terminated | Validation Study of Combined Positron Emission Tomography/Computer Tomography to Diagnose Infection and Inflammation | November 2008 | December 2013 | |
| NCT01820962 | Terminated | Phase 3 | Concentrated Citrate Locking to Reduce the Incidence of CVC-related Complications in Hematological Patients | July 2006 | July 2012 |
| NCT00269100 | Terminated | Prevention of Bacteremia Induced by Debridement of Pressure Ulcer | |||
| NCT00108433 | Terminated | Phase 3 | Linezolid in the Treatment of Hemodialysis Patients With Catheter-Related Gram-Positive Bloodstream Infections | September 2005 | September 2006 |
| NCT03148756 | Terminated | Phase 2 | Efficacy and Safety of Dalbavancin Compared to Standard of Care Antibiotic Therapy for the Completion of Treatment of Patients With Complicated Bacteremia or Infective Endocarditis | May 12, 2017 | August 4, 2017 |
| NCT02208063 | Terminated | Phase 3 | A Phase 3 Telavancin Staphylococcus Aureus (S. Aureus) Bacteremia Trial | December 2014 | April 12, 2018 |
| NCT00435305 | Terminated | Steady State Serum and Epithelial Lining Fluid (ELF) Antibiotics Concentrations Under Continous Infusion | November 2006 | November 2007 | |
| NCT01640886 | Terminated | Study of the Performance of the KeyPath MRSA/MSSA Blood Culture Test - BTA | June 2012 | December 2012 | |
| NCT02633124 | Terminated | N/A | Preventing Catheter-related Bacteremia When Administering Injectable Medications in Premature Infants. | January 2016 | May 2020 |
| NCT00518687 | Terminated | Phase 2/Phase 3 | Efficacy, Immunogenicity, and Safety of a Single Dose of V710 in Adult Patients Scheduled for Cardiothoracic Surgery (V710-003 AM2) | December 2007 | August 2011 |
| NCT02417168 | Terminated | Procalcitonin Levels as a Predictor of Bacteremia in Febrile Pediatric Oncology Patients-Pilot Study | July 1, 2015 | March 1, 2016 | |
| NCT01287832 | Terminated | Phase 4 | Vancomycin Versus Daptomycin for the Treatment of Methicillin-resistant Staphylococcus Aureus Bacteremia Due to Isolates With High Vancomycin Minimum Inhibitory Concentrations (MICs) | June 2011 | January 2012 |
| NCT00428051 | Terminated | Colombia Epidemiologic Surveillance Study | September 2006 | October 2011 | |
| NCT01734694 | Terminated | Phase 4 | Safety and Efficacy of Strategy to Prevent Drug-Induced Nephrotoxicity in High-Risk Patients | October 2011 | September 2012 |
| NCT01724671 | Unknown status | Vancomycin Versus Ceftaroline in Patients With Infections Caused by MRSA That Are Susceptible to Ceftaroline | December 2012 | December 2013 | |
| NCT00862966 | Unknown status | N/A | Central Venous Catheter Lock Solution | April 2009 | |
| NCT02743585 | Unknown status | N/A | Impact of Rapid Pathogen Identification From Blood Cultures (RABbIT) | March 20, 2017 | July 2, 2020 |
| NCT01171547 | Unknown status | Phase 2 | Daptomycin Pharmacokinetics in Continuous Veno-venous Hemodiafiltration | February 2010 | |
| NCT04147975 | Unknown status | Assessment of Assay for Rapid Identification of Bloodstream Infections From Whole Blood | October 1, 2019 | October 30, 2020 | |
| NCT01798537 | Unknown status | Phase 2/Phase 3 | Simplified Selective Digestive Tract Decontamination for the Prevention of Intensive Care Unit Acquired Infections | June 2013 | July 2015 |
| NCT01186172 | Unknown status | Phase 3 | Ethanol Lock for the Salvage of Infected Long-term Vascular Access | June 2010 | June 2013 |
| NCT04304456 | Unknown status | Epidemiology and Determinants of Outcomes of Hospital Acquired Blood Stream Infections in the Intensive Care in Turkey | June 2020 | April 2022 | |
| NCT03208725 | Unknown status | Childhood Acute Illness and Nutrition Network | November 30, 2016 | October 31, 2020 | |
| NCT01265095 | Unknown status | Establish Quantitative PCR to Measure Bacteria Load of the VRE Bacteremia | December 2010 | December 2013 | |
| NCT01301638 | Unknown status | Retrospective Evaluation of Safety and Efficacy of Daptomycin Used in Patients With Serious Gram-positive Infections | February 2011 | ||
| NCT04903886 | Unknown status | Intensive Care Unit Acquired Infections in Patients Colonized With Extended Spectrum Enterobacteriaceae | June 1, 2021 | December 1, 2021 | |
| NCT01352936 | Unknown status | Comparison of Nephrotoxicity and Hospital Costs in Patients With Methicillin-Resistant Staphylococcus Aureus Bacteremia Who Received Vancomycin Versus Teicoplanin Therapy | January 2011 | December 2011 | |
| NCT01392118 | Unknown status | Recurrent ESBL-producing Enterobacteriaceae Bacteremia: Risk Factor, Molecular Character and Susceptibility Change | July 2011 | December 2012 | |
| NCT03714841 | Unknown status | N/A | C-reactive Protein Information and Blood Cultures for Emergency Department Patients With Sepsis | January 21, 2017 | May 15, 2021 |
| NCT00404625 | Unknown status | Infections Caused by ESbL-Producing Enterobacteriaceae in Italy | October 2006 | November 2006 | |
| NCT00057369 | Unknown status | Phase 2 | Safety and Efficacy of Dalbavancin Versus Vancomycin in the Treatment of Catheter-Related Bloodstream Infections | February 2001 | June 2003 |
| NCT00639197 | Unknown status | N/A | UGIST: Ultrasound Guided Internal Jugular Short-Term Central Venous Catheters Tunneling | March 2008 | |
| NCT03354338 | Unknown status | Phase 2 | Amoxicillin to Prevent Bacteria and Inflammatory Biomarkers After Intensive Periodontal Therapy | September 21, 2017 | July 31, 2018 |
| NCT02134106 | Withdrawn | Phase 2/Phase 3 | Randomized-controlled Trial (RCT) on Combination Antibiotic for Infections Caused by Gram-negative Bacteria | January 2015 | December 2015 |
| NCT03108690 | Withdrawn | Phase 4 | Therapeutic Drug Monitoring and Continuous Infusion of Beta-lactam Antibiotics in Patients With Bacteraemia | October 1, 2017 | March 9, 2023 |
| NCT02543957 | Withdrawn | Factors Associated With Increased Risk of Bacteremia and Cholangitis in ERCP With Cholangioscopy | September 2015 | December 2020 | |
| NCT00509847 | Withdrawn | Phase 1/Phase 2 | A Study on the Tolerability and Early Efficacy of hLF1-11 in Patients With Bacteremia Due to S. Epidermidis | February 2009 | October 2009 |
| NCT00505258 | Withdrawn | Phase 2 | Ceftobiprole in the Treatment of Hospitalized Patients With Staphylococcus Aureus Bacteremia | April 2009 |
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0031864
- MeSH unique ID (MeSH (Medical Subject Headings))
- D016470